Adipocyte precursor-derived NRG1 promotes resistance to FGFR inhibition in urothelial carcinoma.
Cancer research
View this publicationCancer research
View this publicationMolecular therapy : the journal of the American Society of Gene Therapy
View this publicationEuropean urology oncology
View this publicationClinical & translational immunology
View this publicationOncoimmunology
View this publicationSignal transduction and targeted therapy
View this publicationBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
View this publicationJournal of the American Academy of Dermatology
View this publicationJournal of neuro-oncology
View this publicationJAMA oncology
View this publication